Labeler
Zydus Pharmaceuticals USA Inc. NDC Codes
Zydus Pharmaceuticals USA Inc. lists 629 finished drug products in the FDA NDC Directory under NDC labeler codes 68382, 70710.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Isotretinoin, Riociguat, brivaracetam, tofacitinib, Eltrombopag, Beizray, Carbidopa and Levodopa, Jaythari, Deflazacort, Ascorbic acid, gadobutrol, Verapamil hydrochloride, Diazepam, gabapentin, oxcarbazepine
- Active ingredients
- Deflazacort, Isotretinoin, Riociguat, Brivaracetam, Tofacitinib citrate, Eltrombopag olamine, Carbidopa, Levodopa, Ascorbic acid, Gadobutrol, Verapamil hydrochloride, Diazepam
- NDC labeler codes
- 68382, 70710
- Strengths (from the 100 most recently listed products)
- Ascorbic acid 500 mg/mL; Gadobutrol 604.72 mg/mL; Docetaxel anhydrous 20 mg/mL; Deflazacort 22.75 mg/mL; Deflazacort 6 mg/1; Deflazacort 18 mg/1; Deflazacort 30 mg/1; Deflazacort 36 mg/1; Riociguat .5 mg/1; Riociguat 1 mg/1; Riociguat 1.5 mg/1; Riociguat 2 mg/1; Riociguat 2.5 mg/1; Fluvoxamine maleate 100 mg/1; Fluvoxamine maleate 150 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Ranibizumab .3 mg/.05mL; Ranibizumab .5 mg/.05mL; Tofacitinib citrate 10 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Injection, Injection, Solution, Capsule, Capsule, Extended release, Kit, Gel, Tablet, Extended release, Tablet, Film coated, Extended release, Suspension, Liquid, Tablet, For suspension, Powder, For solution
- Routes
- Oral, Intravenous, Intramuscular, Subcutaneous, Rectal, Intravitreal
- Drug classes (FDA established)
- Corticosteroid, Serotonin Reuptake Inhibitor, Retinoid, Soluble Guanylate Cyclase Stimulator, Janus Kinase Inhibitor, Thrombopoietin Receptor Agonist, Aromatic Amino Acid, Anti-epileptic Agent, Vitamin C, Gadolinium-based Contrast Agent, Calcium Channel Blocker, Benzodiazepine, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, Tetracycline-class Drug, Vascular Endothelial Growth Factor Inhibitor, Diagnostic Dye, Nitrogen Binding Agent, Sodium-Glucose Cotransporter 2 Inhibitor, Endothelin Receptor Antagonist, Microtubule Inhibitor, CCR5 Co-receptor Antagonist, Kinase Inhibitor, Calcitonin, Oxidation-Reduction Agent, Phosphate Binder, Xanthine Oxidase Inhibitor, Arteriolar Vasodilator, Enzyme Stabilizer, Glucosylceramide Synthase Inhibitor
- HCPCS / J-code
- J2778 — Injection, ranibizumab, 0.1 mg
- Package NDCs
- 169 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| dasatinib | Dasatinib 70 mg/1 | TabletOral | 70710-1743 | 70710-1743-06 | — |
| dasatinib | Dasatinib 80 mg/1 | TabletOral | 70710-1744 | 70710-1744-03 | — |
| dasatinib | Dasatinib 100 mg/1 | TabletOral | 70710-1745 | 70710-1745-03 | — |
| dasatinib | Dasatinib 140 mg/1 | TabletOral | 70710-1746 | 70710-1746-03 | — |
| Sevelamer Hydrochloride | Sevelamer hydrochloride 800 mg/1 | Tablet, Film coatedOral | 70710-2058 | 70710-2058-08 | — |
| Selexipag | Selexipag 200 ug/1 | Tablet, Film coatedOral | 70710-1551 | 70710-1551-0670710-1551-08 | — |
| Selexipag | Selexipag 400 ug/1 | Tablet, Film coatedOral | 70710-1552 | 70710-1552-06 | — |
| Selexipag | Selexipag 600 ug/1 | Tablet, Film coatedOral | 70710-1553 | 70710-1553-06 | — |
| Selexipag | Selexipag 800 ug/1 | Tablet, Film coatedOral | 70710-1554 | 70710-1554-06 | — |
| Selexipag | Selexipag 1000 ug/1 | Tablet, Film coatedOral | 70710-1555 | 70710-1555-06 | — |
| Selexipag | Selexipag 1200 ug/1 | Tablet, Film coatedOral | 70710-1556 | 70710-1556-06 | — |
| Selexipag | Selexipag 1400 ug/1 | Tablet, Film coatedOral | 70710-1557 | 70710-1557-06 | — |
| Selexipag | Selexipag 1600 ug/1 | Tablet, Film coatedOral | 70710-1558 | 70710-1558-06 | — |
| Selexipag TITRATION PACKselexipag | — | Kit | 70710-1653 | 70710-1653-07 | — |
| Levothyroxine Sodium | Levothyroxine sodium anhydrous 100 ug/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 70710-1833 | 70710-1833-01 | — |
| Levothyroxine Sodium | Levothyroxine sodium anhydrous 200 ug/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 70710-1834 | 70710-1834-01 | — |
| Levothyroxine Sodium | Levothyroxine sodium anhydrous 500 ug/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 70710-1835 | 70710-1835-01 | — |
| Zituvimet XRsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | 70710-1804 | 70710-1804-06 | — |
| Zituvimet XRsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 70710-1805 | 70710-1805-06 | — |
| Zituvimet XRsitagliptin and metformin hydrochloride | Sitagliptin 100 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 70710-1806 | 70710-1806-03 | — |
| Sitagliptin and Metformin Hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | 70710-2036 | 70710-2036-06 | — |
| Sitagliptin and Metformin Hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 70710-2037 | 70710-2037-06 | — |
| Sitagliptin and Metformin Hydrochloride | Sitagliptin 100 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 70710-2038 | 70710-2038-03 | — |
| topiramate | Topiramate 50 mg/1 | Capsule, Coated pelletsOral | 68382-498 | 68382-0498-14 | — |
| Topiramate | Topiramate 100 mg/1 | Capsule, Extended releaseOral | 68382-769 | 68382-0769-0168382-0769-0568382-0769-06+2 more | — |
| Topiramate | Topiramate 25 mg/1 | Capsule, Extended releaseOral | 68382-863 | 68382-0863-0168382-0863-0568382-0863-06+2 more | — |
| Topiramate | Topiramate 50 mg/1 | Capsule, Extended releaseOral | 68382-864 | 68382-0864-0168382-0864-0568382-0864-06+2 more | — |
| Scopolamine | Scopolamine 1 mg/3d | Patch, Extended releaseTransdermal | 70710-1846 | 70710-1846-0270710-1846-0470710-1846-07 | — |
| ivabradine | Ivabradine hydrochloride 5 mg/1 | TabletOral | 70710-1471 | 70710-1471-0670710-1471-08 | — |
| ivabradine | Ivabradine hydrochloride 7.5 mg/1 | TabletOral | 70710-1472 | 70710-1472-0670710-1472-08 | — |
| Baclofen | Baclofen 15 mg/1 | TabletOral | 70710-1666 | 70710-1666-01 | — |
| atorvastatin calcium | Atorvastatin calcium trihydrate 80 mg/1 | TabletOral | 70710-1770 | 70710-1770-0070710-1770-0570710-1770-09 | — |
| atorvastatin calcium | Atorvastatin calcium trihydrate 40 mg/1 | TabletOral | 70710-1772 | 70710-1772-0070710-1772-0570710-1772-09 | — |
| atorvastatin calcium | Atorvastatin calcium trihydrate 20 mg/1 | TabletOral | 70710-1775 | 70710-1775-0070710-1775-0570710-1775-09 | — |
| atorvastatin calcium | Atorvastatin calcium trihydrate 10 mg/1 | TabletOral | 70710-1777 | 70710-1777-0070710-1777-0570710-1777-09 | — |
| Indomethacin | Indomethacin 50 mg/1 | SuppositoryRectal | 70710-1958 | 70710-1958-07 | — |
| Chlorpromazine Hydrochloride | Chlorpromazine hydrochloride 25 mg/mL | InjectionIntramuscular | 70710-1849 | 70710-1849-07 | — |
| Chlorpromazine Hydrochloride | Chlorpromazine hydrochloride 25 mg/mL | InjectionIntramuscular | 70710-1850 | 70710-1850-07 | — |
| Zituvimetsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | 70710-1786 | 70710-1786-0670710-1786-08 | — |
| Zituvimetsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | 70710-1787 | 70710-1787-0670710-1787-08 | — |
| Sitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | 70710-1986 | 70710-1986-0670710-1986-08 | — |
| Sitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | 70710-1987 | 70710-1987-0670710-1987-08 | — |
| gabapentin | Gabapentin 600 mg/1 | TabletOral | 68382-607 | 68382-0607-0568382-0607-1668382-0607-77 | — |
| gabapentin | Gabapentin 300 mg/1 | TabletOral | 68382-608 | 68382-0608-0568382-0608-1668382-0608-77 | — |
| Mirabegron | Mirabegron 25 mg/1 | Tablet, Extended releaseOral | 70710-1159 | 70710-1159-0170710-1159-0370710-1159-09 | — |
| Mirabegron | Mirabegron 50 mg/1 | Tablet, Extended releaseOral | 70710-1160 | 70710-1160-0170710-1160-0370710-1160-09 | — |
| zinc sulfatezinc sulfate injection, | Zinc sulfate 1 mg/mL | SolutionIntravenous | 70710-1876 | 70710-1876-07 | — |
| zinc sulfatezinc sulfate injection, | Zinc sulfate 3 mg/mL | SolutionIntravenous | 70710-1877 | 70710-1877-07 | — |
| zinc sulfatezinc sulfate injection, | Zinc sulfate 5 mg/mL | SolutionIntravenous | 70710-1878 | 70710-1878-07 | — |
| Methylene blue | Methylene blue 5 mg/mL | InjectionIntravenous | 70710-1837 | 70710-1837-05 | — |
Zydus Pharmaceuticals USA Inc.: common questions
- What is Zydus Pharmaceuticals USA Inc.'s NDC labeler code?
- 68382, 70710. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Zydus Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J2778 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.